4//SEC Filing
MIGNONE ROBERTO 4
Accession 0000950170-24-074025
CIK 0000818686other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:00 AM ET
Size
8.8 KB
Accession
0000950170-24-074025
Insider Transaction Report
Form 4
MIGNONE ROBERTO
Director
Transactions
- Exercise/Conversion
Restricted Share Units
2024-06-15−21,108→ 0 total→ Ordinary Shares (21,108 underlying) - Exercise/Conversion
Ordinary Shares
2024-06-15+21,108→ 1,595,683 total
Holdings
- 1,500,000(indirect: [See Footnote])
Ordinary Shares
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]The 1,500,000 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Partners, L.P. and Swiftcurrent Offshore Master, Ltd. (the "Funds"). Bridger Management, LLC is the investment adviser to the Funds and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the Ordinary Shares held of record by the Funds. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Funds except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Funds for purposes of Section 16, or for any other purpose.
- [F4]Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001258394
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 8:00 AM ET
- Size
- 8.8 KB